Health News
Analysis: Hospital investors sold on U.S. health reform despite bumps
CHICAGO - Shares of U.S. hospital operators have been on a tear this year, on average posting triple the gains of the broader stock market, as investors tallied up the benefits of President Barack Obama's healthcare reform.
AstraZeneca turnaround is 3-4 year journey, says CEO
LONDON - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief executive said on Tuesday.
EU fines Lundbeck and others 146 million euros for blocking rival drugs
BRUSSELS - European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of 146 million euros ($195 million) for blocking the supply of a cheaper anti-depressant to the market, the first EU sanction against such deals.
Hot flashes common even before menopause
NEW YORK (Reuters Health) - Most women expect hot flashes as a part of the "change of life," but more than half start sweating before menopause has actually begun, according to a survey.
AstraZeneca, Bristol diabetes drug disappoints in key test
LONDON - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over rivals.
Enroll America sets private outreach for Obamacare sign-up
WASHINGTON - Enroll America, a nonprofit group at the center of the political fight over President Barack Obama's healthcare reform law, launched a multi-state grassroots campaign on Tuesday to help sign up millions of uninsured Americans for health coverage in the coming months.
Call for overhaul of drug industry business model
LONDON - Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says.
Outbreak of deadly piglet virus spreads to 13 U.S. states
CHICAGO - A swine virus deadly to young pigs, one never before seen in North America, is spreading rapidly across the United States and proving harder to control than previously believed.
Industry-backed studies more prominent at meetings
NEW YORK (Reuters Health) - Studies that are funded by pharmaceutical companies or involve industry-backed scientists tend to be more prominent at cancer meetings than independent studies, a new report suggests.
Obamacare-like groups tied to lower costs: study
NEW YORK (Reuters Health) - Large independent doctor practices that focus on primary care tend to spend less money and are more likely to meet guidelines for Americans on Medicare than smaller groups, according to a new study.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
